Progression from intestinal metaplasia to adenocarcinoma in Barrett's esophagus. Usefulness of endoscopic surveillance;Progresión de metaplasia intestinal a adenocarcinoma en esófago de Barrett: Utilidad de la vigilancia endoscópica

Revista Medica de Chile

Volumn 131, Issue 6, 2003, Pages 587-596

  Burdiles P , Patricio ^a   Csendes J , Attila ^a   Smok, Gladys ^a   Braghetto M , Italo ^a   Korn B , Owen ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Barrett esophagus; Esophageal diseases; Esophageal neoplasms; Esophagectomy

Indexed keywords

OMEPRAZOLE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; TUMOR RECURRENCE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METAPLASIA; MIDDLE AGED; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 12344257519     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. HAMEETEMAN W, TYTGAT GN, HOUTHOFF HJ, VAN DEN TWEEL JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249-56.
2. WILLIAMSON WA, ELLIS FH JR, GIBB SP, SHAHIAN DM, ARETZ HT, HEATLEY GJ ET AL. Barrett's esophagus: prevalence and incidence of adenocarcinoma. Arch Inter Med 1991; 151: 2212-6.
3. REID BJ, BLOUNT PL, RUBIN CE, LEVINE DS, HAGGITT RC, RABINOBITCH PS ET AL. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992; 102: 1212-9.
4. JANKOWSKI JA, WRIGHT NA, MELTZER SJ, TRIADAFILOUPULOS G, GEBOES K, CASSON AG ET AL. Molecular evolution of the Metaplasia-Dysplasia-Adenocarcinoma sequence in the esophagus. Am J Pathol 1999; 154: 965-73.
5. SCHNELL TG, SONTAG SJ, CHEJFEC G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992; 37: 137-43.
6. CLARK GWB, SMYRK TC, BURDILES P, HOEFT SF, PETERS JH, KIYABU M ET AL. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994; 129: 609-14.
7. CSENDES A, SMOK G, SAGASTUME H, ROJAS J. Estudio prospectivo endoscópico y biópsico de la prevalencia de metaplasia intestinal en la unión gastro-esofágica en controles y en pacientes con reflujo gastroesofágico. Rev Méd Chile 1998; 126: 155-61.
8. SHARMA P, MORALES TG, BHATTACHARYYA A, GAREWAL HS, SAMPLINER RE. Dysplasia in short-segment Barrett's esophagus: a prospective 3 years follow-up. Am J Gastroenterol 1997; 92: 2012-6.
9. WESTON A, KRMPOTICH PT, CHERIAN R, DIXON A, TOPALOVSKI M. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol 1997; 92: 407-13.
10. WESTON A, SHARMA P, TOPALOVSKI M, RICHARDS R, CHERIAN R, DIXON A. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol 2000; 95: 1888-93.
11. CSENDES A, BRAGHETTO I, BURDILES P, PUENTE G, KORN O, DIAZ JC ET AL. Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric and acid reflux test analysis before and late alter operation. Surgery 1998; 123: 645-57.
12. CSENDES A, MALUENDA F, BRAGHETTO I, CSENDES P, HENRÍQUEZ A, QUESADA MS. Location of the lower esophageal sphincter and the squamous-columnar junction in 109 healthy controls and 778 patients with different degrees of endoscopic esophagitis. Gut 1993; 34: 21-7.
13. CSENDES A, BURDILES P, ALVAREZ F, MALUENDA F, HENRÍQUEZ A, QUESADA MS ET AL. Manometric features of mechanically defective lower esophageal sphincter in control subjects and in patients with different degrees of gastroesophageal reflux. Dis Esophagus 1996; 9: 290-4.
14. RIDELL RH, GOLDMAN H, RANSOHOFF DF. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931-68.
15. REID BJ, WEINSTEIN WM, LEWIN KJ, HAGGITT RC, VANDEVENTER G, DENBENSTEN L ET AL. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988; 94: 81-90.
16. HAGGITT RC. Barrett's esophagus, dysplasia and adenocarcinoma. Human Pathol 1994; 25: 982-93.
17. CAMERON AJ. Epidemiologic studies and the development of Barrett's esophagus. Endoscopy 1993; 25: 635-6.
18. HESKETH PJ, CLAPP RW, DOOS WG, SPECHLER SJ. The increasing frequency of adenocarcinoma of the esophagus. Cancer 1989; 64: 526-30.
19. POLKOWSKI W, VAN LANSCHOT JJB, OFFERHAUS GJA. Barrett esophagus and cancer: pathogenesis, carcinogenesis and diagnostic dilemmas. Histol Histopathol 1999; 14: 927-44.
20. KAUER W, BURDILES P, IRELAND AP, CLARK GW, PETERS JH, BREMNER CG ET AL. Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin. Am J Surg 1995; 169: 98-104.
21. BURDILES P. Validación de espectrofotómetro portátil para el estudio del reflujo duodeno-gastroesofágico. Rev Chil Cir 1999; 51: 573-88.
22. CSENDES A, BURDILES P, SMOK G, ROJAS J, FLORES N, DOMIC S ET AL. Hallazgos clínicos, endoscópicos y magnitud del reflujo de contenido gástrico y duodenal en pacientes con metaplasia intestinal cardial y esófago de Barrett corto comparado con controles. Rev Méd Chile 1999; 127: 1321-8.
23. CSENDES A, BURDILES P, BRAGHETTO I, KORN O, DÍAZ JC, ROJAS J. Early and late results of the acid suppression and duodenal diversion operation inpatients with Barrett's esophagus: analysis of 210 cases. World J Surg 2002; 26: 566-76.
24. CSENDES A, SMOK G, BURDILES P, BRAGHETO I, CASTRO C, KORN O. Effect of duodenal diversion on low-grade dysplasia in patients with Barrett's esophagus: analysis of 37 patients. J Gastrointest Surg 2002; 6: 645-52.
25. YOUNES M, LEBOVITZ RM, LECHAGO LV, LECHAGO J. P53 protein accumulation in Barrett's metaplasia, dysplasia and carcinoma: a follow up study. Gastroenterology 1993; 105: 1637-42.
26. KATADA N, HINDER RA, SMYRK T, HIRABAYASHI N, PERDIKIS G, LUND RJ ET AL. Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett's esophagus. Arch Surg 1997; 132: 728-32.
27. WETSCHER G, SCHWELBERGER H, UNGER A, OFFNER F, PROFANTER C, GLASER K ET AL. Refluxed-induced apoptosis of the esophageal mucosa is inhibited in Barrett's epithelium. Am J Surg 1998; 176: 569-73.
28. PELLEGRINI CA. High grade dysplasia in Barrett's esophagus: surveillance or operation? J Gastrointest Surg 2000; 4: 131-4.
29. KATZKA DA, CASTELL DO. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1994; 89: 989-91
30. HOGAN WS. Malignant degeneration of Barrett's esophagus: malignant potential of "short segment" Barrett's esophagus. Dis Esophagus 1995; 8: 93-8.
31. PETERS JH, CLARK GW, IRELAND AP, CHANDRASOMA P, SMYRK TC, DEMEESTER TR. Outcome of adenocarcinomas arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108: 813-21.
32. MCARDLE JC, LEWIN KJ, RANDALL G, WEINSTEIN W. Distribution of dysplasia and early invasive carcinoma in Barrett's esophagus. Hum Pathol 1992; 23: 479-82.